Pfizer has been on an acquisition spree as it seeks to cushion the impact of a projected $17 billion revenue drop by 2030. Pfizer Inc (NYSE: PFE) has closed a $43 billion deal to acquire biotechnology...
Tag: cancer
Pfizer buys Seagen for $43B, boosts access to cancer drugs
Pfizer will spend $43 billion to buy Seagen and deepen its reach into treating cancer. The pharmaceutical giant said Monday that it will pay $229 in cash for each Seagen share. Bothell, Washington-bas...
Pfizer to purchase Seagen in $43 billion all-cash deal, cancer biotech’s stock pops 20%
Pfizer Inc. PFE, -0.18% plans to acquire cancer biotechnology company Seagen Inc. SGEN, -0.59% in a deal with a $43 billion enterprise value, the companies announced Monday morning. Pfizer intends to ...
Cell Therapy Has Shown Near Miraculous Remission Rates In Cancer Patients, But The Growing Industry Relies On This Company – A Uniquely Positioned Ticker In The Weeds?
Nashville, TN –News Direct– Cryoport, Inc. By David Willey, Benzinga Cryoport Inc. (NASDAQ: CYRX) provides the life sciences industry with comprehensive supply chain solutions to support v...
Moderna Stock Jumps On An FDA Boon For Its Cancer Vaccine
Moderna (MRNA) stock jumped late Wednesday after the Food and Drug Administration granted its Merck (MRK)-partnered cancer vaccine a breakthrough designation. X The companies are testing the personali...
Ex-Stanford dean says SBF’s parents helped his family battle cancer
A former dean of Stanford Law School who co-signed Sam Bankman-Fried’s bail said he did so because SBF’s parents have been “the truest of friends” and helped his family through a “harrowing battle wit...
Democrats’ Price Controls Undermine Biden’s Cancer Moonshot
WASHINGTON, DC – MARCH 01: U.S. President Joe Biden delivers the State of the Union address during a … [+] joint session of Congress in the U.S. Capitol’s House Chamber March 01, 202...
GILD Stock: Gilead Posts Its Best Growth In 7 Years As Cancer Drug Sales Rocket
Gilead Sciences (GILD) crushed fourth-quarter expectations Thursday and issued an unexpectedly bullish outlook that buoyed GILD stock. X The company hasn’t seen growth this strong since 2015 at ...
New Evidence That Ultra-Processed Foods May Increase Cancer Risk
A study funded by the World Cancer Research Fund and Cancer Research UK and published in eClinicalMedicine, a Lancet open access clinical journal, provides new evidence of a link between ultra-process...
With Upcoming Ovarian Cancer Data, Analyst Sees 100% Upside For Mersana Therapeutics
Citi initiated coverage on Mersana Therapeutics Inc (NASDAQ: MRSN) with a Buy rating and a price target of $12. The analyst says the topline registrational data (expected in mid-2023) from the UPLIFT...
How A $30 Test Saved My Life
The retinal image that changed the author’s life. That green, oblong patch near the center of my … [+] right eye should not be there. Robert Rapier Author’s Note: Although this article isn...
Uterine Cancer Now Covered By 9/11 Survivors’ Health Program After Years Of Pressure
Topline After years of pressure from 9/11 survivors and first responders, uterine cancer is the latest addition to the growing list of covered health conditions under the World Trade Center’s Health P...
MIT & Mass General Hospital Have Developed An AI System That Can Detect Lung Cancer
Lung cancer is a devastating disease. According to the World Health Organization, lung cancer is one of the most common causes of death worldwide, accounting for nearly 2.21 million cases in 2020 alon...
Robbie Knievel Dies After Pancreatic Cancer Battle, Yet Anti-Vaxxers Blame Covid-19 Vaccines
Robbie Knievel’s storied stuntman career included over 340 jumps. (Photo by Theo Wargo/WireImage for … [+] Turner) WireImage for Turner Daredevil stunt performer Robbie Knievel died on ear...
Jill Biden Has Skin Cancer Removed From Face And Chest
Topline Surgeons on Wednesday removed one cancerous lesion from above first lady Jill Biden’s right eye and another from her chest, White House Dr. Kevin O’Connor said, though she appears to have a go...
AbbVie cuts earnings forecast due to milestone payments
AbbVie Inc. executives lowered their outlook for the quarter and year in a filing with the Securities and Exchange Commission late Friday, which cited research and development expenses and milestone p...
AbbVie Stock Briefly Breaks Out On A New $30 Million Cancer Deal
AbbVie (ABBV) stock briefly broke out Friday after the company signed a $30 million deal with small biotech Immunome (IMNM) in antibody development. X Immunome will use its platform to discover up to ...
Cancer Vaccine Trials—Using Same mRNA Tech Behind Covid Shots—Could Launch In U.K. This September
Topline Trials of cutting-edge cancer vaccines could kick off in the U.K. as soon as September, German Covid vaccine maker BioNTech announced on Friday, part of a new government partnership to fast tr...
BioNTech says it will start cancer vaccine trials in the UK from September
A NHS vaccinator administers the Pfizer-BioNTech Covid-19 booster jab to a woman, at a vaccination centre in London. BioNTech is launching a large-scale trial of mRNA therapies to treat cancer and oth...
Cancer Drug Supplier’s IPO Mints China’s Latest Billionaire
A pedestrian walks past the Shanghai Stock Exchange in Shanghai in 2020. (Photo by HECTOR … [+] RETAMAL/AFP via Getty Images) AFP via Getty Images Today’s listing at the Shanghai Stock Exchange ...
Tennis Legend Martina Navratilova Diagnosed With Throat And Breast Cancer
Topline Tennis great Martina Navratilova revealed in an interview published by Tennis.com Monday that she is battling both throat and breast cancers, though she said the conditions were caught early a...
Modest Mouse’s Jeremiah Green Diagnosed With Stage Four Cancer
LOUISVILLE, KY – JULY 13: Jeremiah Green of the band Modest Mouse performs during the 2018 … [+] Forecastle Music Festival on July 13, 2018 in Louisville, Kentucky. (Photo by Stephen J. Co...
Arcus Biosciences, Gilead shares are down after sharing data about new lung cancer drug
Shares of Arcus Biosciences Inc. RCUS, -27.76% were down 17.2% in premarket trading on Tuesday, the day after the company said the experimental treatment for metastatic non-small cell lung cancer that...
U.S., China Advance Discussions On Pact To Accelerate Cancer Drug Trials
U.S. Food and Drug Administration oncology chief Dr. Richard Pazdur. FDA U.S. and China health experts speaking at an online conference this month suggested that the two countries might be making prog...
EXAS Stock Soars And GH Stock Crashes: Battle Of The Colon Cancer Tests Heats Up
Guardant Health (GH) unveiled pivotal results for its colon cancer-detecting blood test that lagged rival Exact Sciences (EXAS) — leading GH stock to crash Friday. Meanwhile, EXAS stock skyrocketed. X...
Clovis Enters Bankruptcy With Deal to Sell Cancer-Drug Candidate to Novartis
Clovis Oncology Inc., maker of the ovarian and prostate cancer drug Rubraca, filed for bankruptcy over the weekend with a proposed deal in hand to sell its rights to a cancer therapy under development...
Rage Against The Machine’s Tim Cummerford Reveals Cancer Diagnosis
NEW YORK, NEW YORK – AUGUST 08: Tim Commerford of Rage Against the Machine performs at Madison … [+] Square Garden on August 08, 2022 in New York City. (Photo by Theo Wargo/Getty Images) G...
Cancer Focused Clovis Oncology Files For Bankruptcy
Clovis Oncology Inc (NASDAQ: CLVS) has voluntarily initiated a Chapter 11 proceeding in the U.S. Bankruptcy Court and will seek to sell its assets through a court-supervised sales process. The Debtors...
IPO Stock Arcellx Breaks Out On $325 Million Cancer Deal With Gilead
Recent initial public offering Arcellx (ACLX) forged a $325 million multiple myeloma deal with Gilead Sciences (GILD) on Friday, and the IPO stock broke out. X The news comes in lockstep with promisin...
MRTX Stock Crashes As Amgen Rivalry Heats Up With New Lung Cancer Data
Mirati Therapeutics (MRTX) said almost half of patients responded to its lung cancer regimen, but MRTX stock crashed Tuesday as investors questioned whether it could take on traditional chemotherapy. ...
BioNTech upgraded to buy on high hopes for combined flu/COVID vaccine and oncology pipeline
Bank of America analysts upgraded BioNTech SE stock to buy from hold on Thursday, citing excitement about its mRNA technology and the outlook for a combined flu/COVID vaccine and oncology vaccines tha...